Presentation Outcomes After Coronary Stent Implantation in Patients with Metal Allergy Presenter: S. Romero-Brufau April 09, 2012 REGISTER for free or LOG IN to view this content DES/BRS/DCB Policy & Practice Factoid Up Next Presentation TCT 2012 Percutaneous Transcatheter Pulmonary Valve Implantation Induces a Reduction of B-Type Natriuretic Peptide at 30 days. Presenter: Joelle Kefer January 03, 2012 More slides + Presentation TCT 2012 Impact on the need for permanent pacemaker requirement after CoreValve prosthesis implantation with the new Accutrak delivery Catheter System Presenter: Antonio J. Mu?oz-Garc?a January 03, 2012 Presentation TCT 2012 EVEREST II High Surgical Risk Cohort: Clinical Benefit by MR Grade in High Surgical Risk Patients One Year Following MitraClip Therapy. Presenter: Paul Grayburn January 03, 2012 We Recommend
Presentation TCT 2012 Percutaneous Transcatheter Pulmonary Valve Implantation Induces a Reduction of B-Type Natriuretic Peptide at 30 days. Presenter: Joelle Kefer January 03, 2012
Presentation TCT 2012 Impact on the need for permanent pacemaker requirement after CoreValve prosthesis implantation with the new Accutrak delivery Catheter System Presenter: Antonio J. Mu?oz-Garc?a January 03, 2012
Presentation TCT 2012 EVEREST II High Surgical Risk Cohort: Clinical Benefit by MR Grade in High Surgical Risk Patients One Year Following MitraClip Therapy. Presenter: Paul Grayburn January 03, 2012